Rani Therapeutics Holdings (RANI) Free Cash Flow (2020 - 2026)

Rani Therapeutics Holdings' Free Cash Flow history spans 7 years, with the latest figure at -$6.5 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 20.55% to -$6.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$17.1 million, a 50.45% increase, with the full-year FY2025 number at -$18.8 million, up 47.43% from a year prior.
  • Free Cash Flow came in at -$6.5 million for Q1 2026, down from $286000.0 in the prior quarter.
  • The five-year high for Free Cash Flow was $286000.0 in Q4 2025, with the low at -$15.9 million in Q4 2022.
  • Historically, Free Cash Flow has averaged -$9.4 million across 5 years, with a median of -$9.4 million in 2024.
  • Biggest five-year swings in Free Cash Flow: tumbled 131.25% in 2022 and later surged 103.29% in 2025.
  • Year by year, Free Cash Flow stood at -$15.9 million in 2022, then grew by 28.07% to -$11.4 million in 2023, then grew by 24.03% to -$8.7 million in 2024, then skyrocketed by 103.29% to $286000.0 in 2025, then plummeted by 2377.97% to -$6.5 million in 2026.
  • Business Quant data shows Free Cash Flow for RANI at -$6.5 million in Q1 2026, $286000.0 in Q4 2025, and -$5.1 million in Q3 2025.